After the great success and feedback from the Definiens Symposium 2010 in Madrid, Definiens is pleased to announce the International Definiens Symposium 2011. The event will take place at the Moffitt Cancer Center in Tampa, Florida, October 17-18, 2011.  We invite you to join this event to hear about groundbreaking research, meet other users and share your ideas.

The annual Definiens Symposium is the premier forum for Definiens users and developers from around the world to present their latest research, techniques and workflows in life science image and data analysis. Participants come from research institutions, bio-pharmaceutical companies and the healthcare sector. The 2011 Definiens Symposium will be an ideal opportunity to share the latest ideas in state-of-the-art image analysis and to meet international experts from the Definiens community. A social networking event will take place in Tampa’s latin quarter, Ybor City, on Monday evening. Transportation between the Symposium venue and the evening event will be arranged.

When: October 17-18, 2011

Venue: Venue: H. Lee Moffitt Cancer Center and Research Institute, Vincent A. Stabile Research Building, 12902 Magnolia Drive, Tampa, FL 33612, USA

Registration: Click here to register or to learn more.

Sessions will include:
Biomarker Development and Validation
Basic Research and Drug Discovery
Toxicity and Efficacy Studies
Clinical Diagnostics

There have been a number of interesting publications featuring Definiens technology in the first half of 2011. They demonstrate how academic research benefits from Definiens approach to image analysis and illustrate the wide range of possible applications.

Click here to learn more.

Bendtsen et al. Int J Biomed Imaging. 2011; 2011:361589.

Del Río et al. Glia. 2011 May;59(5):821-32.

Eberhardt et al. Glia. 2011 May;59(5):697-707.

Mech et al. PLoS One. 2011 May 5;6(5):e19591.

Nikić et al. Nat Med. 2011 Apr;17(4):495-9.

Pickl et al. Journal of Clinical Oncology, 2011. Vol 29, No 15_suppl.

Wilbertz et al. Mod Pathol. 2011 Jul;24(7):944-53.

From the editor: There are interesing news from Metamark Genetics. A current study in Cancer Cell illustrates the great potential of their innovative technology for the development of novel test for determining the prognosis of early stage melanoma. Congratulations!

Read the full press release or the Cancer Cell article to learn more.